# Open House Biologika Rabattverträge 2026-25 - Follitropin alfa Open · Tender ## At a glance Techniker Krankenkasse is procuring Pharmaceutical products (CPV 33600000) in Hamburg (DE600). It is divided into 3 lots. The notice gives 31 July 2028, 23:58 (UTC+02:00) as the deadline. Procedure type: Open. ### From the notice Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa (es werden mehrere Lose gebildet, siehe Angaben bei den jeweiligen Losen) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.08.2026. Der Vertrag endet spätestens am 31.07.2028, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen. ## Key facts - Status: Open - Deadline: 31 July 2028, 23:58 (UTC+02:00) (in 627 days) - Buyer: [Techniker Krankenkasse](https://inteliwert.com/company/org_FNYK6B6QVARBEDT4PFFEPH9SAV/techniker-krankenkasse), Hamburg, DE - Place of performance: Hamburg (DE600) - Main CPV: Pharmaceutical products (CPV 33600000) - Procedure: Open - Lots: 3 - First published: 4 June 2026, 14:58 (UTC+02:00) Source: [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005). Each fact is from the official notice, last checked 12 November 2026, 09:30 (UTC+01:00). Fact sheet: [Inteliwert fact sheet: Open House Biologika Rabattverträge 2026-25 - Follitropin alfa — Techniker Krankenkasse, deadline 31 July 2028, 23:58 (UTC+02:00). A product of Bandpey GmbH.](https://inteliwert.com/cards/opp_QY8JEN449T0AEVS58JMW8E4QT7/ntv_DYKABB3NS24JHDGVRVYKYG8KCW/en-sheet.png) (PNG, 1600 × 900) ## Lots (3) ### Lot LOT-0001: Follitropin alfa (Fertigarzneimittel GONAL-f (R)) Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen. - CPV: Pharmaceutical products (CPV 33600000) - Place: Hamburg (DE600) - Deadline: 31 July 2028, 23:58 (UTC+02:00) ### Lot LOT-0002: Follitropin alfa (Fertigarzneimittel Bemfola (R)) Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen. - CPV: Pharmaceutical products (CPV 33600000) - Place: Hamburg (DE600) - Deadline: 31 July 2028, 23:58 (UTC+02:00) ### Lot LOT-0003: Follitropin alfa (Fertigarzneimittel Ovaleap(R)) Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen. - CPV: Pharmaceutical products (CPV 33600000) - Place: Hamburg (DE600) - Deadline: 31 July 2028, 23:58 (UTC+02:00) ## Timeline - 4 June 2026, 14:58 (UTC+02:00): Original notice, Notice, version 01 (Contract or concession notice – standard regime), [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005) ## Classification - CPV codes: Pharmaceutical products (CPV 33600000) - NUTS regions: Hamburg (DE600) ## Official documents - [vergabe.tk.de](https://vergabe.tk.de/Satellite/notice/CXR0YYRY6D7/documents) ## Questions and answers ### When is the deadline? The official notice gives 31 July 2028, 23:58 (UTC+02:00) as the deadline. ### Who is the buyer? Techniker Krankenkasse, Hamburg, DE. ### What is being procured (CPV)? Pharmaceutical products (CPV 33600000). ### Where is the work performed (NUTS)? Hamburg (DE600). ### Is it divided into lots? Yes, into 3 lots: Follitropin alfa (Fertigarzneimittel GONAL-f (R)), Follitropin alfa (Fertigarzneimittel Bemfola (R)) and Follitropin alfa (Fertigarzneimittel Ovaleap(R)). ### Which procedure is used? Open. ### How do I submit a bid? On the official notice or the portal it names. Inteliwert does not submit bids. [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005) ### Am I eligible? Inteliwert does not judge eligibility. The selection criteria are in the official notice. [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005) ## Companies that might fit *Possible match based on public information* Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances. - [G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH](https://inteliwert.com/company/org_8118XE58TF6J4YKBJKDN5JRDG9/g-l-pharma-gmbh-vertreten-durch-g-l-pharma-deutschland-gmbh) · Hamburg · SME (from the award notice) - Won a contract in CPV group 336 (2026-07-08): [Evidence](https://inteliwert.com/tender/opp_1CR5ZMNMQ3G57237KNGFVPKRVZ/arzneimittelausschreibung-2026-vergebene-auftraege), checked 12 Nov 2026 - Seat in the same district as the place of performance: [Evidence](https://inteliwert.com/company/org_8118XE58TF6J4YKBJKDN5JRDG9), checked 12 Nov 2026 - [Norgine GmbH](https://inteliwert.com/company/org_5XF8BQ5ZW1YBVFJ61XGHKYZKK9/norgine-gmbh) · Wettenberg · SME (from the award notice) - Won a contract in CPV group 336 (2026-09-29): [Evidence](https://inteliwert.com/tender/opp_ZFYYHJJ569EAZ7XFM9T1MVY0R4/bekanntmachung-vergebener-auftraege-nach-130-a-abs-8-sgb-v-und-130-c-sgb-v-zu-de), checked 12 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XF8BQ5ZW1YBVFJ61XGHKYZKK9), checked 12 Nov 2026 - [Klinge Pharma GmbH](https://inteliwert.com/company/org_CJRDNDYWQ77ZJKPBEP8NS8PFV1/klinge-pharma-gmbh) · Holzkirchen · SME (from the award notice) - Won a contract in CPV group 336 (2026-07-08): [Evidence](https://inteliwert.com/tender/opp_1CR5ZMNMQ3G57237KNGFVPKRVZ/arzneimittelausschreibung-2026-vergebene-auftraege), checked 12 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_CJRDNDYWQ77ZJKPBEP8NS8PFV1), checked 12 Nov 2026 - [EVER Pharma GmbH](https://inteliwert.com/company/org_CYWH4X3R7HEY5TW2R9PRTV43J0/ever-pharma-gmbh) · Gröbenzell · SME (from the award notice) - Won a contract in CPV group 336 (2026-07-08): [Evidence](https://inteliwert.com/tender/opp_1CR5ZMNMQ3G57237KNGFVPKRVZ/arzneimittelausschreibung-2026-vergebene-auftraege), checked 12 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_CYWH4X3R7HEY5TW2R9PRTV43J0), checked 12 Nov 2026 - [APONTIS PHARMA Deutschland GmbH & Co. KG](https://inteliwert.com/company/org_0YF469QXQBP0AS5F54FHM9KNBX/apontis-pharma-deutschland-gmbh-co-kg) · Monheim am Rhein · SME (from the award notice) · New to public tenders - Won a contract in CPV group 336 (2026-09-29): [Evidence](https://inteliwert.com/tender/opp_18MPVP6PE0BE4KFA55KV4H0PKE/bekanntmachung-vergebener-auftraege-nach-130-a-abs-8-sgb-v-und-130-c-sgb-v-zu-de), checked 12 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_0YF469QXQBP0AS5F54FHM9KNBX), checked 12 Nov 2026 ## More from this buyer Other published opportunities of this buyer in the indexed notices, open ones first. - [Open-House-Rabattverträge 2024-12](https://inteliwert.com/tender/opp_FEWBS5N2CYCTB94NQ4C372X9YC/open-house-rabattvertraege-2024-12) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 30 Nov 2028, 23:58 (UTC+01:00) · [Official notice](https://ted.europa.eu/de/notice/-/detail/782487-2026), Last checked 12 Nov 2026, 01:30 (UTC+01:00) - [Gebäudereinigung 21](https://inteliwert.com/tender/opp_EYHCAT14VR4B4ACACWQRFEDDCT/gebaeudereinigung-21) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 17 Dec 2026, 12:00 (UTC+01:00) · [Official notice](https://ted.europa.eu/de/notice/-/detail/773005-2026), Last checked 12 Nov 2026, 06:30 (UTC+01:00) - [Open House Originale Rabattverträge 2024-12 - Tofacitinib](https://inteliwert.com/tender/opp_CK4653S86F49VSVB3MTNAGSR2X/open-house-originale-rabattvertraege-2024-12-tofacitinib) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 31 Mar 2027, 23:58 (UTC+02:00) · [Official notice](https://ted.europa.eu/de/notice/-/detail/772079-2026), Last checked 7 Nov 2026, 07:11 (UTC+01:00) - [TK BIZ Salzhausen - Fachplaner Tragwerk](https://inteliwert.com/tender/opp_CGBCKAZW7G2BDBJCNZTARQ3669/tk-biz-salzhausen-fachplaner-tragwerk) Open · Buyer: Techniker Krankenkasse · Place: DE933 (Niedersachsen) · [Official notice](https://ted.europa.eu/de/notice/-/detail/772001-2026), Last checked 12 Nov 2026, 06:30 (UTC+01:00) - [Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)](https://inteliwert.com/tender/opp_4T2SXRGSAVWEG43408Y4P17V6T/open-house-biologika-rabattvertraege-2026-33-pertuzumab-trastuzumab-wirkstoffkom) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 31 Dec 2028, 23:58 (UTC+01:00) · [Official notice](https://ted.europa.eu/de/notice/-/detail/772750-2026), Last checked 12 Nov 2026, 06:30 (UTC+01:00) ## Related opportunities - [Open House Biologika Rabattverträge 2026-23 - Darbepoetin alfa](https://inteliwert.com/tender/opp_6DXXP3771R6T2PY462MHRAQEYX/open-house-biologika-rabattvertraege-2026-23-darbepoetin-alfa) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 31 Jul 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/e00fabcf-c7df-41e5-97a3-15fa5767ce24), Last checked 12 Nov 2026, 10:30 (UTC+01:00) - [Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)](https://inteliwert.com/tender/opp_DTZ3HMGTQ88FETVVXJ3DKAWZ88/open-house-biologika-rabattvertraege-2026-24-aflibercept-atc-s01la05-wirkstaerke) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 31 Jul 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/62e74483-7eff-4a16-bc7d-9f820b41909a), Last checked 12 Nov 2026, 10:30 (UTC+01:00) - [Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)](https://inteliwert.com/tender/opp_N3XRVNS734JYCF404NW6TPZDNQ/open-house-biologika-rabattvertraege-2025-25-aflibercept-atc-s01la05-wirkstaerke) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 30 Nov 2026, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/ea1a8a5a-1848-4543-888f-587c92a4a33f), Last checked 12 Nov 2026, 10:30 (UTC+01:00) - [Open House Biologika Rabattverträge 2026-22 - Ustekinumab](https://inteliwert.com/tender/opp_R3YRJZWQQK0EHGDGHS8BVHA9TB/open-house-biologika-rabattvertraege-2026-22-ustekinumab) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 31 Jul 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/fb6886be-c910-487c-a576-895dec9fd759), Last checked 12 Nov 2026, 09:30 (UTC+01:00) - [Rahmenvereinbarung für Laborbedarf und Chemikalien](https://inteliwert.com/tender/opp_1Y2NG16AAYYY5GC7QRFB2KRSTT/rahmenvereinbarung-fuer-laborbedarf-und-chemikalien) Open · Buyer: Universität Hamburg · Place: DE600 (Hamburg) · Deadline: 9 Dec 2026, 09:00 (UTC+01:00) · Published value: €700,000 excl. VAT · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/53d7ed95-5f3d-4568-aedc-ec1968fd144c), Last checked 12 Nov 2026, 08:11 (UTC+01:00) - [Open-House-Rabattverträge 2024-07](https://inteliwert.com/tender/opp_N5Q4XJVHY7CKQP49RXZ1TWK3BK/open-house-rabattvertraege-2024-07) Open · Buyer: Techniker Krankenkasse · Place: DE600 (Hamburg) · Deadline: 30 Jun 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/e2089bc3-054d-4f04-8db4-27a282d8b909), Last checked 11 Nov 2026, 19:31 (UTC+01:00) ## Source - Publisher: Bekanntmachungsservice - Licence: [CC0 1.0](https://creativecommons.org/publicdomain/zero/1.0/) - Official notice: [https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005](https://oeffentlichevergabe.de/ui/de/notices/3570c732-f4ca-4279-858a-5fd76d437005) - Last checked: 12 November 2026, 09:30 (UTC+01:00) The official notice is authoritative. Inteliwert shows what the notice states and links to it. --- Page: https://inteliwert.com/tender/opp_QY8JEN449T0AEVS58JMW8E4QT7/open-house-biologika-rabattvertraege-2026-25-follitropin-alfa Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert. Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.